Showing results (81-90 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|August 2, 2014
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical rolesDavid Baumeister, Georgina Barnes, Giovanni Giaroli, et al.Therapeutic Advances in Psychopharmacology|July 26, 2017
Antipsychotic-induced hyperprolactinemia in Tourette syndromeJudith J G Rath, Marlies E J Deen, Hessel van Houten, et al.Therapeutic Advances in Psychopharmacology|May 4, 2016
Ibogaine-associated cardiac arrest and death: case report and review of the literatureJessica A Meisner, Susan R Wilcox, Jeremy B RichardsTherapeutic Advances in Psychopharmacology|February 26, 2016
A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorderDawn F Ionescu, Maurizio Fava, Daniel Ju Hyung Kim, et al.Therapeutic Advances in Psychopharmacology|November 12, 2015
Factors predicting use of laxatives in outpatients stabilized on clozapineLoren Bailey, Seema Varma, Nina Ahmad, et al.Therapeutic Advances in Psychopharmacology|November 12, 2015
Amelioration of deficit syndrome of schizophrenia by norepinephrine reuptake inhibitorSaeed Shoja Shafti, Mohammad Sadeghe Jafarabad, Reza AziziTherapeutic Advances in Psychopharmacology|January 19, 2018
Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention serviceAndrew Shaker, Rowena JonesTherapeutic Advances in Psychopharmacology|January 19, 2018
When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipityPenelope Lowe, Amir Krivoy, Lilla Porffy, et al.Therapeutic Advances in Psychopharmacology|July 7, 2018
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trialThomas R E Barnes, Verity Leeson, Carol Paton, et al.Therapeutic Advances in Psychopharmacology|July 7, 2018
Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatmentTomasz Litwin, Petr Dusek, Tomasz Szafrański, et al.Pageof 55